Literature DB >> 16630315

Measles immunity and immunisation status in Australian children 1 to 4 years of age.

Geoffry G Hogg1, Raelene J Darlington, Katharine G Hogg, Rosemary Lester.   

Abstract

AIM: Determine measles seropositivity and vaccine coverage in children aged 1 to 4 years inclusive. Compare data in those who produced immunisation records and those who relied on parental recall. Establish variables associated with seropositivity.
DESIGN: Population- and area-based, cluster sample of 1- to 4-year-olds; households surveyed by trained interviewer.
SETTING: Australia-wide, excluding New South Wales. Questionnaires completed between February and April 1995.
SUBJECTS: 2117 completed questionnaires were returned for children aged 1 to 4 years, 923 of whom provided a sufficient blood sample for analysis.
RESULTS: Overall seropositivity was 86% for the 923 children tested and was strongly associated with previous immunisation (P < 0.001) and age (P < 0.001), but not with parental report of a previous measles diagnosis (P = 0.581). Eight hundred and forty-three (91%) reported previous measles immunisation, with 760 (90%) of these testing seropositive. Four hundred and ninety-one (55%) parents/guardians produced immunisation records, while 400 (45%) relied on recall. Immunised children whose parents relied on recall were equally likely to be seropositive as children whose parents produced records. The 923 children tested were representative of the 2117 who completed questionnaires in all factors except age, where children below 2 years old were under represented (P < 0.001).
CONCLUSIONS: These data support the current second routine measles immunisation prior to school entry, and reinforce the need to promote the first routine dose to achieve measles elimination.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16630315     DOI: 10.1111/j.1440-1754.2006.00823.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  5 in total

1.  Seropositivity of measles antibodies in the Israeli population prior to the nationwide 2018 - 2019 outbreak.

Authors:  Ravit Bassal; Victoria Indenbaum; Rakefet Pando; Tal Levin; Eilat Shinar; Doron Amichay; Mira Barak; Anat Ben-Dor; Adina Bar Haim; Ella Mendelson; Dani Cohen; Tamy Shohat
Journal:  Hum Vaccin Immunother       Date:  2020-10-29       Impact factor: 3.452

2.  Why children are not vaccinated against measles: a cross-sectional study in two Nigerian States.

Authors:  Anne Cockcroft; Muhammad U Usman; Obrian F Nyamucherera; Henry Emori; Bong Duke; Nisser Ali Umar; Neil Andersson
Journal:  Arch Public Health       Date:  2014-12-29

3.  Proportion of children aged 9-59 months reached by the 2017 measles supplementary immunization activity among the children with or without history of measles vaccination in Lilongwe district, Malawi.

Authors:  Hamilton Wales Kainga; Steven Ssendagire; Jacquellyn Nambi Ssanyu; Sarah Nabukeera; Noel Namuhani; Fred Wabwire Mangen
Journal:  PLoS One       Date:  2021-01-11       Impact factor: 3.240

4.  One size does not fit all: local determinants of measles vaccination in four districts of Pakistan.

Authors:  Anne Cockcroft; Neil Andersson; Khalid Omer; Noor M Ansari; Amir Khan; Ubaid Ullah Chaudhry; Umaira Ansari
Journal:  BMC Int Health Hum Rights       Date:  2009-10-14

5.  Measles epidemic in pakistan: in search of solutions.

Authors:  Ak Niazi; R Sadaf
Journal:  Ann Med Health Sci Res       Date:  2014-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.